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Decades of epidemiological studies and
three carefully controlled randomized clin-
ical trials have definitively shown that male
circumcision (MC) reduces risks for HIV
transmission from women to men by as
much as 55% [1]. Male circumcision is
therefore more protective against HIV
transmission than even the most promising
vaccines and topical microbicides. The
protective biological mechanisms of MC
are most likely a combination of removing
HIV vulnerable cells that are present at high
densities in the foreskin, particularly Lan-
gerhans cells, keratinization of mucous
membranes, and reduction of penile trauma
during intercourse. There is also evidence
that MC offers protection against other
sexually transmitted infections, further re-
ducing the risk of HIV acquisition and
transmission [2]. Although MC offers little,
if any, direct protective benefits to women
who engage in vaginal or anal intercourse
with HIV infected men, or to male receptive
anal intercourse partners of HIV-positive
men, population-level reductions in HIV
prevalence among men will ultimately lead
to fewer infections in their sex partners.
Efforts to scale up MC for HIV
prevention have thus far focused on
promoting circumcision for young adult
men, and there is ample evidence for high
levels of acceptability in this group [3,4].
Cost-effectiveness studies show that the
monetary expenditures of scaling up MC
in southern Africa are offset by dramatic
savings in productivity and health care
expenditures. For example, Kahn et al. [5]
found that full-scale coverage of MC in
South Africa’s Gauteng province, which
has an HIV prevalence of over 25%,
would save $2.4 million over a 20-year
period. Because MC is a partially effective
HIV prevention strategy, its effects are
cumulative over men’s sexually active
lifetimes and will, therefore, have most
impact when implemented prior to sexual
debut [6]. Neonatal circumcision is safer
than circumcision in adulthood, carrying
lower risks for surgical errors, infection,
and other adverse events. As with adult
MC, there is also evidence that neonatal
MC has high acceptability for HIV
prevention [7]. Circumcising male infants
has therefore emerged as an important
consideration in policy discussions for
scaling up MC for HIV prevention.
The Cost-Effectiveness of
Neonatal Male Circumcision
In a study published in this issue of PLoS
Medicine, Agnes Binagwaho and colleagues
conducted a comparative cost-effective-
ness analysis of neonatal, adolescent, and
adult MC scale-up in Rwanda, a country
with a moderate adult HIV prevalence of
about 3% [8,9]. The study used the
perspective of the Rwandan government
as the health care payer and used standard
costs associated with the procedure as well
as costs associated with HIV testing,
treatment, and care. The model was based
on current estimates of HIV incidence in
Rwanda and an estimated 55% protective
effect of MC. Analyses once again showed
that MC is a cost-saving HIV prevention
intervention, with both neonatal and adult
MC saving Rwanda resources for each
HIV infection averted. Furthermore, neo-
natal MC is less expensive than adult and
adolescent MC, rendering greater divi-
dends despite the time lag between the
procedure and averted infections.
As with any HIV prevention strategy,
the benefits of MC are most apparent
when HIV incidence is highest. However,
sensitivity analyses showed that neonatal
MC remains cost saving even under very
low estimates of HIV incidence. Binag-
waho et al. conclude that providing
universal access to MC, including neonatal
MC, in conjunction with other effective
HIV prevention interventions will reduce
the overall cost of effectively fighting
severe HIV epidemics driven by hetero-
sexual transmission.
Cultural Factors Can Undermine
the Public Health Impact of MC
The case for MC, including neonatal
MC, for HIV prevention is biologically
and medically compelling. However, as
with any other public health intervention,
the effectiveness of MC will be determined
by access and uptake. Cost-effectiveness
analyses such as those reported by Binag-
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utility of increased access to neonatal MC.
However, uptake may turn out to be a far
greater challenge than can be estimated in
cost-effectiveness analyses.
Rwanda was an interesting choice for a
neonatal cost-effectiveness analysis because
the country may represent a best case
scenario for neonatal MC scale-up in Africa.
More than 90% of the Rwandan population
is Christian, and in Christianity there is little
if any religious and cultural meaning
attached to MC. Thus, while the country
does not already routinely circumcise at
b i r t h ,t h e r ew i l ll i k e l yb el i t t l er e s i s t a n c et o
scaling up neonatal MC. Indeed, Rwanda
has already initiated a national MC pro-
gram that focuses on infants as one of its first
priority populations [9].
Resistance to neonatal MC will surely
be greater in African cultures where MC
in young men is central to concepts of
masculinity and maturity, often in places
where HIV prevalence is much higher
than Rwanda. In South Africa, for exam-
ple, Xhosa communities circumcise young
men in a rite of passage that is key to
gender definitions, marking the transition
from boyhood to manhood. Cultural
beliefs and conceptualizations of mascu-
linity, including what it means to be a
man, are turned upside down when
neonatal MC is introduced to cultures
where MC is a pubertal rite of passage
[10]. These cultural realities may at least
in part account for why Rwanda is rapidly
scaling up MC programs for HIV preven-
tion whereas South Africa, a country with
nearly four times the national HIV
prevalence of Rwanda, remains stalled
on implementing MC. The power of
cultural and religious beliefs is readily
apparent to orthodox Jews or Muslims
who contemplate the ramifications of any
public health recommendation that op-
poses MC. For example, when New York
City’s health department launched a
public health campaign to oppose an
ancient form of ritualistic neonatal cir-
cumcision, ultra-Orthodox Jewish leaders
held a rally against the campaign [11].
Recognizing and understanding the cul-
tural and religious beliefs attached to MC
in areas most seriously affected by HIV/
AIDS will be crucial in the successful
scale-up of this effective HIV prevention
strategy.
Ignoring Behavioral Factors Can
Undermine MC for HIV
Prevention
Cultural and religious beliefs are not the
only nonbiological factors to consider in
scaling-up neonatal MC. Anticircumcision
groups have long existed and are increas-
ingly vocal as MC programs for HIV
prevention are promoted [12]. Antici-
rcumcision groups resemble other antisci-
ence and antimedicine extremists includ-
ing AIDS denialists who refute public
health realities to maintain entrenched
belief systems [13].
Another behavioral consideration in the
scale-up of MC is the potential for risk
compensation. In other words, men who
elect MC to reduce their risks for HIV
may subsequently stop using condoms and
possibly increase their number of sex
partners in response to their lower per-
ceived risk [14]. While risk compensation
following MC may occur, the evidence
thus far is mixed [14–16]. It is possible that
boys who grow up circumcised will not
experience compensatory behavior be-
cause they will not undergo reductions in
risk perception. However, an increase in
beliefs that a man’s circumcision status
determines his vulnerability to HIV will
likely shift social norms, with the potential
for community-wide risk compensation.
The contextualization and framing of MC
must therefore be tailored to each indi-
vidual culture to avoid adverse behavioral
ramifications of implementing neonatal
MC [17]. The slow uptake of MC may
be due to a failure to take into account the
cultural and behavioral issues surrounding
MC. This slow pace risks offsetting the
potential long term impact of MC for HIV
prevention.
Conclusion
MC offers one of the few available
effective HIV prevention interventions.
Scaling up MC in southern Africa has the
potential to stem entire HIV epidemics,
saving countless lives. Lifetime protection
against HIV, and therefore reductions in
population levels of HIV/AIDS, can be
realized when circumcision occurs prior to
sexual debut. The cost-savings of neonatal
MC are compelling and suggest that
implementation is economically feasible in
developing countries hit hardest by HIV/
AIDS. Neonatal MC should therefore be
considered a priority in comprehensive
HIV prevention plans for southern Africa.
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